Austar Lifesciences Ltd (6118.HK) announced a profit for its full year that Increased, from the same period last year
The company's bottom line came in at RMB33.805 million, or RMB0.07 per share. This compares with RMB16.079 million, or RMB0.03 per share, last year.
The company's revenue for the period rose 2.1% to RMB1.531 billion from RMB1.500 billion last year.
Austar Lifesciences Ltd earnings at a glance (GAAP) :
-Earnings: RMB33.805 Mln. vs. RMB16.079 Mln. last year.-EPS: RMB0.07 vs. RMB0.03 last year.-Revenue: RMB1.531 Bln vs. RMB1.500 Bln last year.
For comments and feedback contact: editorial@rttnews.com
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.